Cyclacel Pharmaceuticals's market cap is currently $3.89M. The company's EPS TTM is $-11.214; its P/E ratio is ―; Cyclacel Pharmaceuticals is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 420.00K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 420.00K	$ -32.00K	$ -43.00K	$ -20.00K	$ -20.00K
Operating Income	$ -25.45M	$ -27.66M	$ -22.94M	$ -10.64M	$ -9.68M
EBITDA	$ -25.42M	$ -27.62M	$ -22.69M	$ -10.62M	$ -9.66M
Net Income	$ -22.55M	$ -21.20M	$ -18.89M	$ -8.45M	$ -7.83M
Balance Sheet
Cash & Short-Term Investments	$ 3.38M	$ 18.34M	$ 36.56M	$ 33.41M	$ 11.88M
Total Assets	$ 8.80M	$ 27.50M	$ 42.59M	$ 36.80M	$ 15.31M
Total Debt	$ 37.00K	$ 106.00K	$ 30.00K	$ 1.06M	$ 1.19M
Net Debt	$ -3.34M	$ -18.24M	$ -36.53M	$ -32.35M	$ -10.69M
Total Liabilities	$ 8.20M	$ 11.99M	$ 5.32M	$ 3.54M	$ 3.61M
Stockholders' Equity	$ 607.00K	$ 15.51M	$ 37.26M	$ 33.26M	$ 11.70M
Cash Flow
Free Cash Flow	$ -16.12M	$ -20.83M	$ -18.57M	$ -8.03M	$ -9.46M
Operating Cash Flow	$ -16.11M	$ -20.83M	$ -18.54M	$ -7.93M	$ -9.45M
Investing Cash Flow	$ -6.00K	$ -7.00K	$ -27.00K	$ -96.00K	$ 28.00K
Financing Cash Flow	$ 848.00K	$ 3.00M	$ 21.74M	$ 29.50M	$ 3.85M

Currency in USD

Cyclacel Pharmaceuticals Earnings and Revenue History

Income Statement >

Cyclacel Pharmaceuticals Debt to Assets

Balance Sheet >

Cyclacel Pharmaceuticals Cash Flow

Cash Flow >

Cyclacel Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing